Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The pill and cancer.

C La Vecchia

    European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
    |August 25, 2000
    PubMed
    Summary

    Oral contraceptives (OC) use has been extensively studied for cancer risk, particularly for breast, genital tract, liver, and melanoma. Emerging research suggests a potential reduced risk of colorectal cancer, though further study is needed.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Fertility drugs and breast and ovarian cancer.

    Lancet (London, England)·1995
    Same author

    Cancer mortality in Europe, 1990-92.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·1995
    Same author

    [Trends in skin cancers in the Vaud canton, 1976-1992].

    Revue medicale de la Suisse romande·1995
    Same author

    Trends of skin cancer in the Canton of Vaud, 1976-92.

    British journal of cancer·1995
    Same author

    Pancreatitis and the risk of pancreatic cancer.

    Pancreas·1995
    Same author

    Mortality from benign prostatic hyperplasia: worldwide trends 1950-92.

    Journal of epidemiology and community health·1995

    Area of Science:

    • Oncology
    • Reproductive Health
    • Epidemiology

    Background:

    • Extensive research has examined the association between oral contraceptive (OC) use and various cancer risks.
    • Primary focus has been on breast, female genital tract, liver cancer, and cutaneous malignant melanoma.

    Discussion:

    • Current evidence primarily summarizes the established links between OC use and specific cancers.
    • Preliminary data suggests a potential inverse relationship between OC use and colorectal cancer risk.
    • This potential link requires further investigation before influencing clinical recommendations.

    Key Insights:

    • Established OC-cancer associations are well-documented for breast, genital tract, liver, and melanoma.
    • A controversial, preliminary link suggests reduced colorectal cancer risk with OC use.
    • Insufficient evidence currently exists to guide contraception choices based on colorectal cancer risk.

    Outlook:

    • Further research is crucial to validate the preliminary findings on OC use and colorectal cancer.
    • Future studies should aim to clarify the complex relationship between hormonal contraception and neoplasm development.
    • Longitudinal studies are needed to establish causality and inform evidence-based contraception counseling.

    Related Experiment Videos